๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Mechanisms of Hypertension in the Central Nervous System

โœ Scribed by Takao Kubo

Publisher
John Wiley and Sons
Year
2007
Weight
18 KB
Volume
38
Category
Article
ISSN
0931-7597

No coin nor oath required. For personal study only.

โœฆ Synopsis

Abstract

ChemInform is a weekly Abstracting Service, delivering concise information at a glance that was extracted from about 200 leading journals. To access a ChemInform Abstract, please click on HTML or PDF.

๐Ÿ“œ SIMILAR VOLUMES

Mechanism of stem cells in the central n
Mechanism of stem cells in the central nervous system
โœ Clas B. Johansson ๐Ÿ“‚ Article ๐Ÿ“… 2003 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 246 KB ๐Ÿ‘ 1 views

## Abstract Injury to the central nervous system (CNS) can result in severe functional impairment. The brain and spinal cord, which constitute the CNS, have been viewed for decades as having a very limited capacity for regeneration. However, over the last several years, the body of evidence support

Gliogenesis in the central nervous syste
Gliogenesis in the central nervous system
โœ J.C. Lee; M. Mayer-Proschel; M.S. Rao ๐Ÿ“‚ Article ๐Ÿ“… 2000 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 332 KB ๐Ÿ‘ 2 views

Multipotential neuroepithelial stem cells are thought to give rise to all the differentiated cells of the central nervous system (CNS). The developmental potential of these multipotent stem cells becomes more restricted as they differentiate into progressively more committed cells and ultimately int

Dysfunction of the central nervous syste
Dysfunction of the central nervous system
โœ James B. Brierley ๐Ÿ“‚ Article ๐Ÿ“… 1967 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 343 KB ๐Ÿ‘ 2 views
Intranasal delivery to the central nervo
Intranasal delivery to the central nervous system: Mechanisms and experimental considerations
โœ Dhuria, Shyeilla V. (author);Hanson, Leah R. (author);Frey, William H. (author) ๐Ÿ“‚ Article ๐Ÿ“… 2010 ๐Ÿ› John Wiley and Sons Inc. ๐ŸŒ English โš– 325 KB

The blood-brain barrier (BBB) limits the distribution of systemically administered therapeutics to the central nervous system (CNS), posing a significant challenge to drug development efforts to treat neurological and psychiatric diseases and disorders. Intranasal delivery is a noninvasive and conve